Membrane structure modulation, protein kinase Cα activation, and anticancer activity of minerval

Molecular Pharmacology

Volumn 67, Issue 2, 2005, Pages 531-540

  Martínez, Jordi ^a   Vögler, Oliver ^a   Casas, Jesús ^a   Barceló, Francisca ^a   Alemany, Regina ^a   Prades, Jesús ^a   Nagy, Tünde ^a   Baamonde, Carmela ^a   Kasprzyk, Philip G ^b   Terés, Silvia ^a   Saus, Carlos ^a   Escribá, Pablo V ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b Biomeasure Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN A; CYCLIN B; CYCLIN D3; CYCLIN DEPENDENT KINASE 2; DOXORUBICIN; LIPOSOME; MEMBRANE LIPID; MESSENGER RNA; MINERVAL; PROTEIN; PROTEIN KINASE C ALPHA; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME BINDING; FEMALE; GLIOMA CELL; HEART MUSCLE FIBER MEMBRANE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MEMBRANE STRUCTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; CELL LINE, TUMOR; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GROWTH INHIBITORS; HUMANS; LIPOSOMES; OLEIC ACIDS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; STEARIC ACIDS;

EID: 13444284041     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.000778     Document Type: Article

References (57)

1. WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization. Biochem J 337:607-616.
2. Barceló F, Prades J, Funari SS, Frau J, Alemany R, and Escribá PV (2004) The hypotensive drug 2-hydroxyoleic acid modifies the structural properties of model membranes. Mol Membr Biol 21:261-268.
3. Belachew S, Aguirre AA, Wang H, Vautier F, Yuan X, Anderson S, Kirby M, and Gallo V (2002) Cyclin-dependent kinase-2 controls oligodendrocyte progenitor cell cycle progression and is downregulated in adult oligodendrocyte progenitors. J Neurosci 22:8553-8562.
4. Bloj B and Zilversmit DB (1976) Asymmetry and transposition rates of phosphatidylcholine in rat erythrocyte ghosts. Biochemistry 15:1277-1283.
5. Caponigro F, French RC, and Kaye SB (1997) Protein kinase C: a worthwhile target for anticancer drugs? Anticancer Drugs 8:26-33.
6. Cayrol C and Ducommun B (1998) Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21. Oncogene 17:2437-2444.
7. Dawson RM, Irvine RF, Bray J, and Quinn PJ (1984) Long-chain unsaturated diacylglycerols cause a perturbation in the structure of phospholipid bilayers rendering them susceptible to phospholipase attack. Biochem Biophys Res Commun 125:836-842.
8. Deshmukh DS, Vorbrodt AW, Lee PK, Bear WD, and Kuizon S (1988) Studies on the submicrosomal fractions of bovine oligodendroglia: lipid composition and glycolipid biosynthesis. Neurochem Res 13:571-582.
9. 1 arrest. J Cell Sci 113:3025-3035.
10. Dobashi Y, Shoji M, Kitagawa M, Noguchi T, and Kameya T (2000) Simultaneous suppression of cdc2 and cdk2 activities induces neuronal differentiation of PC12 cells. J Biol Chem 275:12572-12580.
11. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, and Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
12. Epand RM (1985) Diacylglycerols, lysolecithin or hydrocarbons markedly alter the bilayer to hexagonal phase transition temperature of phosphatidylethanolamines. Biochemistry 24:7092-7095.
13. Epand RM and Bottega R (1988) Determination of the phase behaviour of phosphatidylethanolamine admixed with other lipids and the effects of calcium chloride: implications for protein kinase C regulation. Biochim Biophys Acta 944:144-154.
14. Epand RM, Epand RF, Ahmed N, and Chen R (1991) Promotion of hexagonal phase formation and lipid mixing by fatty acids with varying degrees of unsaturation. Chem Phys Lipids 57:75-80.
15. Epand RM and Lester DS (1990) The role of membrane biophysical properties in the regulation of protein kinase C activity. Trends Pharmacol Sci 11:317-320.
16. Escribá PV, Ferrer-Montiel AV, Ferragut JA, and Gonzalez-Ros JM (1990) Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: implications in drug-resistance phenomena. Biochemistry 29:7275-7282.
17. Escribá PV, Morales P, and Smith A (2002) Membrane phospholipid reorganization differentially regulates metallothionein and heme oxygenase by heme-hemopexin. DNA Cell Biol 21:355-364.
18. Escribá PV, Ozaita A, Ribas C, Miralles A, Fodor E, Farkas T, and Garcia-Sevilla JA (1997) Role of lipid polymorphism in G protein-membrane interactions: nonlamellar-prone phospholipids and peripheral protein binding to membranes. Proc Natl Acad Sci USA 94:11375-11380.
19. Escribá PV, Sánchez-Dominguez JM, Alemany R, Perona JS, and Ruiz-Gutierrez V (2003) Alteration of lipids, G proteins and PKC in cell membranes of elderly hypertensives. Hypertension 41:176-182.
20. Escribá PV, Sastre M, and Garcia-Sevilla JA (1995) Disruption of cellular signaling pathways by daunomycin through destabilization of nonlamellar membrane structures. Proc Natl Acad Sci USA 92:7595-7599.
21. Funari SS, Barcelo F, and Escribá PV (2003) Effects of oleic acid and its congeners, elaidic and stearic acids, on the structural properties of phosphatidylethanolamine membranes. J Lipid Res 44:567-575.
22. Giorgione J, Epand RM, Buda C, and Farkas T (1995) Role of phospholipids containing docosahexaenoyl chains in modulating the activity of protein kinase C. Proc Natl Acad Sci USA 92:9767-9770.
23. 2+ on structure of phosphatidylcholine/ phosphatidyl-serine bilayers. Biophys J 66:382-393.
24. Goñi FM and Alonso A (1999) Structure and functional properties of diacylglycerols in membranes. Prog Lipid Res 38:1-48.
25. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, and Lassar AB (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Wash DC) 267:1018-1021.
26. WAF1/Cip1 transcription through Sp1 sites by histone deacetylase inhibitor apicidin: involvement of protein kinase C. J Biol Chem 276:42084-42090.
27. Israel M, Idriss JM, Koseki Y, and Khetarpal VK (1987) Comparative effects of adriamycin and DNA-non-binding analogues on DNA, RNA and protein synthesis in vitro. Cancer Chemother Pharmacol 20:277-284.
28. Janes N (1996) Curvature stress and polymorphism in membranes. Chem Phys Lipids 81:133-150.
29. 2 gonadotrope cell lines. Endocrinology 143:1386-1403.
30. Kashiwagi M, Ohba M, Watanabe H, Ishino K, Kasahara K, Sanai Y, Taya Y, and Kuroki T (2000) PKCε associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes. Oncogene 19:6334-6341.
31. Kinnunen PKJ (1996) On the molecular-level mechanism of peripheral protein-membrane interactions induced by lipids forming inverted non-lamellar phases. Chem Phys Lipids 81:151-166.
32. Koubi L, Tarek M, Bandyopadhyay S, Klein ML, and Scharf D (2002) Membrane structural perturbations caused by anesthetics and nonimmobilizers: a molecular dynamics investigation. Biophys J 81:3339-3345.
33. Lester DS and Baumann D (1991) Action of organic solvents on protein kinase C. Eur J Pharmacol 206:301-308.
34. Lu G, Morinelli TA, Meier KE, Rosenzweig SA, and Egan BM (1996) Oleic acid-induced mitogenic signaling in vascular smooth muscle cells. A role for protein kinase C. Circ Res 79:611-618.
35. Mañes S, Mira E, Gomez-Mouton C, Lacalle RA, Keller P, Labrador JP, and Martínez AC (1999) Membrane raft microdomains mediate frot-rear polarity in migrating cells. EMBO (Eur Mol Biol Organ) J 18:6211-6220.
36. Michaeli J, Busquets X, Orlow I, Younes A, Colomer D, Marks PA, Rifkind RA, and Kolesnick RN (1992) A rise and fall in 1,2-diacylglycerol content signal hexamethylene bisacetamide-induced erythropoiesis. J Biol Chem 267:23463-23466.
37. Mosior M, Golini ES, and Epand RM (1996) Chem specificity and physical properties of the bilayer in the regulation of protein kinase C by anionic phospholipids: evidence for the lack of a specific binding site for phosphatidylserine. Proc Natl Acad Sci USA 93:1907-1912.
38. Park JW, Jang MA, Lee YH, Passaniti A, and Kwon TK (2001) p53-independent elevation of p21 expression by PMA results from PKC-mediated mRNA stabilization. Biochem Biophys Res Commun 280:244-248.
39. Cip1 in muscle and other terminally differentiating cells. Science (Wash DC) 267:1024-1027.
40. Perkins WR, Dause RB, Parente RA, Minchey SR, Neuman KC, Gruner SM, Taraschi TF, and Janoff AS (1996) Role of lipid polymorphism in pulmonary surfactant. Science (Wash DC) 273:330-332.
41. Pinton P, Tsuboi T, Ainscow EK, Pozzan T, Rizzuto R, and Rutter GA (2002) Dynamics of glucose-induced membrane recruitment of protein kinase C βII in living pancreatic islet β-cells. J Biol Chem 277:37702-37710.
42. Pintus G, Tandolini B, Maioli M, Posadino AM, Gaspa L, and Ventura C (1999) Heparin down-regulates the phorbol ester-induced protein kinase C gene expression in human endothelial cells: enzyme-mediated autoregulation of protein kinase C-α and -δ genes. FEBS Lett 449:135-140.
43. Puskás LG, Kitajka K, Nyakas C, Barceló-Coblijn G, and Farkas T (2003) Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus. Proc Natl Acad Sci USA 100:1580-1585.
44. Rothman JE and Lenard J (1977) Membrane asymmetry. Science (Wash DC) 195:743-753.
45. Shen Y-MA, Chertihin OI, Biltonen RL, and Sando JJ (1999) Lipid-dependent activation of protein kinase C-α by normal alcohols. J Biol Chem 274:34036-34044.
46. Sieber FE, Traystman RJ, Brown PR, and Martin LJ (1998) Protein kinase C expression and activity after global incomplete cerebral ischemia in dogs. Stroke 29:1445-1452.
47. Spector AA and Burns CP (1987) Biological and therapeutic potential of membrane lipid modification in tumors. Cancer Res 47:4529-4537.
48. Sperandio S, de Belle I, and Bredesen DE (2000) An alternative, nonapoptotic form of programmed cell death, Proc Natl Acad Sci USA 97:14376-14381.
49. Strobeck MW, Fribourg AF, Puga A, and Knudsen ES (2000) Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest. Oncogene 19:1857-1867.
50. Sun XG and Rotenberg SA (1999) Overexpression of protein kinase Cα in MCF-10A human breast cells engenders dramatic alterations in morphology, proliferation and motility. Cell Growth Differ 10:343-352.
51. Triton TR and Yee G (1982) The anticancer agent adriamycin can be actively cytotoxic without entering cells. Science (Wash DC) 217:248-250.
52. Vereb G, Szollosi J, Matko J, Nagy P, Farkas T, Vigh L, Matyus L, Waldmann TA, and Damjanovich S (2003) Dynamic, yet structured: the cell membrane three decades after the Singer-Nicolson model. Proc Natl Acad Sci USA 100:8053-8058.
53. Verkleij AJ, Zwaal RF, Roelofsen B, Comfurius P, Kastelijn D, and van Deenen LL (1973) The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim Biophys Acta 323:178-193.
54. Vogler O, Casas J, Capó D, Nagy T, Borchert G, Martorell G, and Escribá PV (2004) The Gβγ dimer drives the interaction of heterotrimeric Gi proteins with nonlamellar membrane structures. J Biol Chem 8:36540-36545.
55. Walker DH, Adami GR, Dold KM, and Babiss LE (1995) Misregulated expression of the cyclin dependent kinase 2 protein in human fibroblasts is accompanied by the inability to maintain a G2 arrest following DNA damage. Cell Growth Differ 6:1053-1061.
56. Ward NE and O'Brian CA (1993) Inhibition of protein kinase C by N-myristoylated peptide substrate analogs. Biochemistry 32:11903-11909.
57. cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells. J Biol Chem 272:29967-29974.